Insider Trading - Eliem Therapeutics Inc. (ELYM)

Real time insider trading transaction history:

  1. Insiders must file a Form 4 covering their trades within two business days.
  2. Section 16 prohibits insiders from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for Eliem Therapeutics Inc.

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-08-12
Purchase
2021-08-16
4:21 pm
Eliem Therapeutics Inc. ELYM AI ETI LLC
Access Industries Holdings LLC
ACCESS INDUSTRIES MANAGEMENT LLC
Blavatnik Len
10% Owner
800,000 $12.5 $10,000,000 5,009,400
(Direct)
View
2021-08-12
Purchase
2021-08-16
4:47 pm
Eliem Therapeutics Inc. ELYM RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund L.P.
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
3,200,000 $12.5 $40,000,000 841,087
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2021-08-09
Option Award
2021-08-11
5:14 pm
N/A
2031-08-08
Eliem Therapeutics Inc. ELYM Levin Andrew David
Director
20,000 $0 20,000
(Direct)
View
2021-08-09
Option Award
2021-08-11
5:17 pm
N/A
2031-08-08
Eliem Therapeutics Inc. ELYM Tate Simon
Director
20,000 $0 20,000
(Direct)
View
2021-08-09
Option Award
2021-08-11
5:20 pm
N/A
2031-08-08
Eliem Therapeutics Inc. ELYM Rosenberg Adam Joseph
Director
20,000 $0 20,000
(Direct)
View
2021-08-09
Option Award
2021-08-11
5:23 pm
N/A
2031-08-08
Eliem Therapeutics Inc. ELYM Ratcliffe Liam
Director
20,000 $0 20,000
(Direct)
View
2021-08-09
Option Award
2021-08-11
5:28 pm
N/A
2031-08-08
Eliem Therapeutics Inc. ELYM RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund L.P.
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
20,000 $0 20,000
(Indirect)
View
2021-08-12
Conversion
2021-08-16
4:21 pm
N/A
N/A
Eliem Therapeutics Inc. ELYM AI ETI LLC
Access Industries Holdings LLC
ACCESS INDUSTRIES MANAGEMENT LLC
Blavatnik Len
10% Owner
8,418,800 $0 5,009,400
(Direct)
View
2021-08-12
Conversion
2021-08-16
4:47 pm
N/A
N/A
Eliem Therapeutics Inc. ELYM RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund L.P.
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
13,446,573 $0 841,087
(Indirect)
View